Form 4 for BLFS BIOLIFE SOLUTIONS INC
Accepted 2022-05-17 00:00:00 ET · period of report 2022-05-13 · accession 0001437749-22-012850 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 2022-05-17 | 2022-05-13 | BLFS | Rice Michael | CEO, Dir | S - Sale | $12.32 | -165 | 360.3K | -0.0% | -$2,033 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2022-05-13 | S | D | 165 | $12.32 | 360,326 | D | — | — |